| Financial Year |
March 31 2023 |
| Monetary Funds |
1,939,745,272.17 |
| Held-for-trading Financial Assets |
1,593,909,632.93 |
| Notes Receivable |
2,000,000.00 |
| Accounts Receivable |
402,696,422.44 |
| Advances to Suppliers |
51,995,944.80 |
| Other Receivables |
181,948,800.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,878,643,160.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
10,000,000.00 |
| Other Current Assets |
176,889,764.47 |
| Total Current Assets |
7,646,763,754.64 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
85,441,062.77 |
| Long-term Equity Investment |
1,426,054,425.04 |
| Investment Properties |
660,603,950.00 |
| Fixed Assetes |
572,035,988.49 |
| Under-construction Projects |
13,506,451.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
103,156,078.97 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,339,732.34 |
| Deferred Income Tax Assets |
62,522,441.55 |
| Other Non-Current Assets |
7,974,000.00 |
| Sub-Total of Non-Current Assets |
3,127,698,642.44 |
| Total Assets |
10,774,462,397.08 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,000,000.00 |
| Accounts Payable |
2,248,103,682.07 |
| Accounts Received In Advance |
86,948,553.51 |
| Employee Compensation Payable |
18,773,192.06 |
| Taxes Payable |
22,028,039.64 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
770,329,695.30 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
500,000,000.00 |
| Other Current Liabilities |
173,741,134.86 |
| Sub-Total of Current Liabilities |
4,212,122,809.19 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
397,400,000.00 |
| Sub-Total of Non-Current Liabilities |
398,473,559.29 |
| Total Liabilities |
4,610,596,368.48 |
| Paid-In Capital(Or Share Stock) |
1,598,902,832.00 |
| Capital Surplus |
2,252,542,785.40 |
| Surplus Reserve |
205,046,946.02 |
| LESS:Treasury Stock |
50,010,943.41 |
| Undistributed Profits |
2,036,407,590.93 |
| Minority Stockholder's Interest |
-44,718,520.21 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,208,584,548.81 |
| Owner's Equity（Stockholder's Equity） |
6,163,866,028.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,774,462,397.08 |
